Ausperbio Therapeutics Inc.
Clinical trials sponsored by Ausperbio Therapeutics Inc., explained in plain language.
-
New shot aims to tame hepatitis b without daily pills
Disease control Not yet recruitingThis phase 2 trial tests an experimental drug called AHB-137 in 70 adults with chronic hepatitis B who are already on antiviral pills. The drug is given as a shot under the skin. The goal is to see if it can lower the virus to undetectable levels and allow some people to stop the…
Phase: PHASE2 • Sponsor: AusperBio Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New injection aims to tame chronic hepatitis b
Disease control Not yet recruitingThis early-phase study tests a new injectable drug called AHB-171 in 144 adults with chronic hepatitis B. The main goals are to check the drug's safety and how the body processes it. Some participants will also take standard oral antivirals. The study is not yet recruiting.
Phase: PHASE1 • Sponsor: AusperBio Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC